Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 907978, 6 pages
http://dx.doi.org/10.1155/2015/907978
Case Report

A Case of Primary Breast Diffuse Large B-Cell Lymphoma Treated with Chemotherapy Followed by Elective Field Radiation Therapy: A Brief Treatment Pattern Review from a Radiation Oncologist’s Point of View

1Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University, Incheon 405-760, Republic of Korea
2Department of Internal Medicine, Gil Medical Center, School of Medicine, Gachon University, Incheon 405-760, Republic of Korea
3Department of Pathology, Ewha Womans University School of Medicine, Seoul 158-710, Republic of Korea

Received 6 January 2015; Accepted 20 April 2015

Academic Editor: Katsuhiro Tanaka

Copyright © 2015 Kyu Chan Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Avenia, A. Sanguinetti, R. Cirocchi et al., “Primary breast lymphomas: a multicentric experience,” World Journal of Surgical Oncology, vol. 8, article 53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Lyons, J. Myles, B. Pohlman, R. M. Macklis, J. Crowe, and R. L. Crownover, “Treatment and prognosis of primary breast lymphoma: a review of 13 cases,” American Journal of Clinical Oncology, vol. 23, no. 4, pp. 334–336, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ryan, G. Martinelli, M. Kuper-Hommel et al., “Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the international extranodal lymphoma study group,” Annals of Oncology, vol. 19, no. 2, pp. 233–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. P. Ferguson, “Intraepithelial lymphocytes and macrophages in the normal breast,” Virchows Archiv A, vol. 407, no. 4, pp. 369–378, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-Y. Yhim, H. J. Kang, Y. H. Choi et al., “Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study,” BMC Cancer, vol. 10, article 321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Yang, R.-G. Lang, F.-F. Liu et al., “Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases,” Zhonghua Bing Li Xue Za Zhi, vol. 40, no. 2, pp. 79–84, 2011. View at Google Scholar · View at Scopus
  7. N. Anne and R. Pallapothu, “Lymphoma of the breast: a mimic of inflammatory breast cancer,” World Journal of Surgical Oncology, vol. 9, article 125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. R. Zack, S. G. Trevisan, and M. Gupta, “Primary breast lymphoma originating in a benign intramammary lymph node,” The American Journal of Roentgenology, vol. 177, no. 1, pp. 177–178, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. W. C. Jennings, R. S. Baker, S. S. Murray et al., “Primary breast lymphoma: the role of mastectomy and the importance of lymph node status,” Annals of Surgery, vol. 245, no. 5, pp. 784–789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Y. Cheah, B. A. Campbell, and J. F. Seymour, “Primary breast lymphoma,” Cancer Treatments Reviews, vol. 40, no. 8, pp. 900–908, 2014. View at Google Scholar
  11. M. Uesato, Y. Miyazawa, Y. Gunji, and T. Ochiai, “Primary non-Hodgkin's lymphoma of the breast: report of a case with special reference to 380 cases in the Japanese literature,” Breast Cancer, vol. 12, no. 2, pp. 154–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. P. Miller, S. Dahlberg, J. R. Cassady et al., “Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma,” The New England Journal of Medicine, vol. 339, no. 1, pp. 21–26, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Coiffier, “Rituximab therapy in malignant lymphoma,” Oncogene, vol. 26, no. 25, pp. 3603–3613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Villa, J. M. Connors, T. N. Shenkier, R. D. Gascoyne, L. H. Sehn, and K. J. Savage, “Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy,” Annals of Oncology, vol. 21, no. 5, pp. 1046–1052, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Avilés, C. Castañeda, N. Neri, S. Cleto, and M. J. Nambo, “Rituximab and dose dense chemotherapy in primary breast lymphoma,” Haematologica, vol. 92, no. 8, pp. 1147–1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. B. A. Campbell, “The role of radiation therapy in the treatment of stage I-II diffuse large B-cell lymphoma,” Current Hematologic Malignancy Reports, vol. 8, pp. 236–238, 2013. View at Publisher · View at Google Scholar
  17. A. Avilés, S. Delgado, M. J. Nambo, N. Neri, E. Murillo, and S. Cleto, “Primary breast lymphoma: results of a controlled clinical trial,” Oncology, vol. 69, no. 3, pp. 256–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Haioun, C. Besson, E. Lepage et al., “Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients,” Annals of Oncology, vol. 11, no. 6, pp. 685–690, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yoshida, N. Nakamura, Y. Sasaki et al., “Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype,” Modern Pathology, vol. 18, no. 3, pp. 398–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. P. Salzberg, J. C. Maragulia, O. W. Press et al., “Primary breast diffuse large B cell lymphoma: a distinct clinical entity,” in Proceedings of the 54th Annual Meeting and Exposition of the American Society of Hematology (ASH '12), Atlanta, Ga, USA, December 2012.
  21. B. Mouna, B. Saber, E. H. Tijaniel, M. Hind, T. Amina, and E. Hassan, “Primary malignant non-Hodgkin's lymphoma of the breast: a study of seven cases and literature review,” World Journal of Surgical Oncology, vol. 10, article 151, 2012. View at Publisher · View at Google Scholar
  22. M. Seker, A. Bilici, B. O. Ustaalioglu et al., “Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast,” Archives of Gynecology and Obstetrics, vol. 284, no. 2, pp. 405–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Niitsu, M. Okamoto, H. Nakamine, and M. Hirano, “Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma,” Leukemia Research, vol. 32, no. 12, pp. 1837–1841, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-F. Zhao, F. Jiao, H.-Q. Liang, Q.-C. Luo, and L.-W. Zhao, “Primary malignant non-Hodgkin's lymphoma of the breast: a case report,” Oncology Letters, vol. 8, no. 6, pp. 2596–2600, 2014. View at Publisher · View at Google Scholar
  25. P. Validire, M. Capovilla, B. Asselain et al., “Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors,” The American Journal of Hematology, vol. 84, no. 3, pp. 133–139, 2009. View at Publisher · View at Google Scholar · View at Scopus